Geraniol

Geraniol

SCHEMBL668456

CC(C)=CCC/C(C)=C/CO.CCO

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Geraniol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.91
ALOX15 P16050 3/20 0.91
MEN1 O00255 2/20 0.91
CYP3A4 P08684 2/20 0.91
ALDH1A1 P00352 3/20 0.86
MAPT P10636 2/20 0.86
UGT1A1 P22309 1/20 0.86
SQLE Q14534 7/20 0.61
KDM4E B2RXH2 1/20 0.52
ICMT O60725 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Geraniol SCHEMBL1665820 1.00 KMT2A (0.91) KMT2AALOX15MEN1CYP3A4ALDH1A1
Nerol SCHEMBL5372628 1.00 KMT2A (0.91) KMT2AALOX15MEN1CYP3A4ALDH1A1
Geraniol SCHEMBL8124286 1.00 KMT2A (0.91) KMT2AALOX15MEN1CYP3A4ALDH1A1
Solanesol SCHEMBL6317060 0.98 KMT2A (0.91) KMT2AALOX15MEN1CYP3A4ALDH1A1
Farnesol SCHEMBL11215938 0.98 KMT2A (0.91) KMT2AALOX15MEN1CYP3A4ALDH1A1
Farnesol SCHEMBL1549561 0.98 KMT2A (0.91) KMT2AALOX15MEN1CYP3A4ALDH1A1
Geraniol SCHEMBL2874022 0.95 KMT2A (1.00) KMT2AALOX15MEN1CYP3A4ALDH1A1
Geraniol SCHEMBL21173796 0.95 KMT2A (1.00) KMT2AALOX15MEN1CYP3A4ALDH1A1
Geraniol SCHEMBL8676054 0.95 KMT2A (1.00) KMT2AALOX15MEN1CYP3A4ALDH1A1
Geraniol SCHEMBL19824 0.95 KMT2A (1.00) KMT2AALOX15MEN1CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety THE PROCTER & GAMBLE COMPANY (US) 2025-02-25 US claimed
US-20250051370-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2025-02-13 US claimed
US-20220064191-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2022-03-03 US claimed
EP-3218425-B1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2020-05-13 EP claimed
WO-2017196762-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2017-11-16 WO claimed
US-20170327647-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2017-11-16 US claimed
EP-3218425-A1 SILICONE COMPOUNDS The Procter and Gamble Company (US) 2017-09-20 EP claimed
CN-105928122-A Air purifier for increasing air humidity 舒尔环保科技(合肥)有限公司 2016-09-07 CN claimed
WO-2016077513-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2016-05-19 WO claimed
US-20160137674-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2016-05-19 US claimed
EP-0529804-B1 Catalysts comprising Copper and the use thereof in the preparation of aldehydes UNION CAMP CORP (US) 1996-04-17 EP claimed
EP-0101578-B1 DISPENSING FRAGRANCES Union Camp Corporation (US) 1986-12-30 EP claimed
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety THE PROCTER & GAMBLE COMPANY (US) 2025-02-25 US disclosed
US-20250051370-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2025-02-13 US disclosed
US-20240102060-A1 ENZYMES AND METHODS FOR FERMENTATIVE PRODUCTION OF MONOTERPENE ESTERS ISOBIONICS B.V. (NL) 2024-03-28 US disclosed
CN-108136386-B Method for preparing ruthenium/iron/carbon carrier catalyst 巴斯夫欧洲公司 2024-01-30 CN disclosed
CN-1219194-A Delivery system comprising a release barrier loaded zeolite PROCTER & GAMBLE (US) 1999-06-09 CN disclosed
US-5756109-A ESTERIFICATION INHIBITOR FOR SKIN DISORDER CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) 1998-05-26 US disclosed
US-5139562-A Exposure to cineole, fenchone, menthol THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1992-08-18 US disclosed
WO-1992010934-A1 INHIBITION OF POTATO SPROUTING USING VOLATILE MONOTERPENES THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) 1992-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137674-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS KMT2A 1800/4885ALOX15 2271/4885MEN1 49/4885
US-20250051370-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS KMT2A 1800/4885ALOX15 2271/4885MEN1 49/4885
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety SMS, SRM, AAAS KMT2A 396/4885ALOX15 2826/4885MEN1 31/4885
US-20220064191-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS KMT2A 1800/4885ALOX15 2271/4885MEN1 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.